Back to directory

Barbara Ann Karmanos Cancer Institute

McLaren Health Care

AL Amyloidosis ATTRv ATTRwt AA Amyloidosis 4 Rare Subtypes

Contact Information

Primary Contact

Christy Houde

Program Manager, Myeloma and Hematologic Malignancies

Activity level

  • Patients per year100
  • New diagnoses per year25

Multidisciplinary team

  • HematologyOn-site
  • CardiologyOn-site
  • NephrologyOn-site
  • NeurologyThrough formal referral
  • PathologyOn-site
Other specialists
PulmonologyGenetic counsellorsNuclear medicine specialistsCardiac imaging specialistsRadiologistsAllied health professionals (NP, PA)Palliative carePsychology / counsellingSocial work

Diagnostic capabilities

  • EchocardiographyOn-site
  • Cardiac MRI (CMR)Through network partners
  • Radionuclide imagingOn-site
  • Histopathology (Congo red)On-site
  • Amyloid typingThrough network partners
  • Genetic testingThrough network partners
  • Fat aspiration / labial gland biopsyOn-site
  • Organ biopsiesOn-site

Subtype expertise

  • ALYes
  • ATTRvYes
  • ATTRwtYes
  • AAYes
Rare subtypes
Localised amyloidosisApolipoprotein A-I (AApoA1)Apolipoprotein A-IV (AApoAIV)Leukocyte chemotactic factor 2 (ALECT2)

Treatment options

  • Chemotherapy (AL)Available on-site
  • TTR stabilizersAvailable on-site
  • RNA interferenceAvailable on-site
  • Antisense oligonucleotidesAvailable on-site
  • Stem cell transplantAvailable on-site
  • Heart transplantNot available
  • Kidney transplantNot available
  • Liver transplantNot available

Patient support services

Services offered
Psychosocial supportSocial workGenetic counsellingNutritional guidance (dietitian)Specialty pharmacyPatient support groupsPalliative careFinancial or access counselling

Networks & telemedicine

  • Telemedicine / virtual consultationYes
  • Part of a formal amyloidosis networkYes
  • Diagnostic services for other organisationsNo

Last confirmed: 30 April 2026

Listings are self-reported by each center and have not been independently verified by the International Society of Amyloidosis (ISA). Inclusion in this directory does not constitute certification, accreditation, or endorsement by ISA.